Other languages Jubilant Pharmova Limited NSE India S.E.

Equities

JUBLPHARMA

INE700A01033

Market Closed - NSE India S.E. Other stock markets 05:10:48 16/05/2024 pm IST			5-day change	1st Jan Change
721.7 ^INR	+0.87%		+6.26%	+32.31%

03/05	Jubilant Pharmova Appoints CEO for Radiopharma Business	MT
25/04	Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jubilant Pharmova Appoints CEO for Radiopharma Business	03/05
Jubilant Pharmova Subsidiary's Canadian Manufacturing Unit Gets Five Observations from US FDA	25/04
India's Jubilant Pharmova posts quarterly profit	02/02
Jubilant Pharmova Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02/02
Jubilant Pharmova Limited Announces the Resignation of Kumar Ramamurthi as Director and Whole-Time Director, Effective October 31, 2023	27/23/27
Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	27/23/27
Domino's India operator Jubilant beats Q2 profit estimates on cheaper launches	25/23/25
Jubilant Pharmova Limited Recommends Dividend for the Year Ended March 31, 2023, Payable on or Before September 29, 2023	08/23/08
Jubilant Pharmova Limited Recommends Dividend for the Financial Year Ended March 31, 2023	31/23/31
Jubilant Pharmova's Consolidated Profit Plunges in Fiscal Q1	20/23/20
Jubilant Pharmova Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	19/23/19
Indian shares set for flat start ahead of key earnings	19/23/19
Late Rally Led by Consumer Goods, Financials Lifts Indian Equities to Close Higher	30/23/30
Jubilant Pharmova Limited Announces Change in Directorate	30/23/30
INDIA STOCKS-Indian shares rise to five-month high on improved global cues	30/23/30
Jubilant Pharmova Limited Recommends Dividend for the Financial Year Ended March 31, 2023	29/23/29
Jubilant Pharmova Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/23/29
Jubilant Pharmova Limited Appoints Shirish G. Belapure as Additional Director (Non-Executive, Independent)	08/23/08
Jubilant Pharmova Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03/23/03
Jubilant Pharmova Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	21/22/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Jubilant Pharmova Limited NSE India S.E.

Equities

JUBLPHARMA

INE700A01033

Other languages

Filters